For the second consecutive year, Quintiles has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards. Presented at the World Vaccine Congress now under way in Washington, D.C., the awards recognize and celebrate individuals, organizations and initiatives which have made significant contributions over the past 12 months.
The Best CRO award is presented to the honored CRO following two rounds of evaluation. First, customers vote for their preferred CRO online prior to the World Vaccine Congress to arrive at a list of five companies per category. Then, a judging panel makes its selection based on information provided in the following criteria:
“We’re proud to be recognized by our customers and peers as the Best CRO,” said Dr. Christopher Cabell, senior vice president, Therapeutic Delivery Unit. “We work every day to advance the development of quality vaccines and anti-infective products. This achievement celebrates our commitment to create a healthier world.”
Two Quintiles scientific and operational experts presented as part of the technical seminars offered at the World Vaccine Congress.
Quintiles helped develop or commercialize 73% (11 of 15) of 2011’s best selling Vaccine products or compounds.
For more news on vaccines in clinical trials, check out the edition of ACT Direct e-news that went out this morning.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.